arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PFIZER INC

PFE
$26.02 ▲ +0.23 (+0.89%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
20 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

PFIZER INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $147.9B
Dividend Yield 6.61%
Revenue Growth -1.6%
Op. Margin
ROIC
FCF / Share $1.60
Trailing P/E 19.0x
Price / Book 1.7x
FCF Yield 6.1%
Debt / Equity 0.71
info Valuation on last close. End-of-day price, Aug 6, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$62.58B
↓ -1.6%
Net Income Profit after all expenses
$7.77B
↓ -3.2%
FCF / Share Free cash flow per share
$1.60
↓ -8.0%
Long-Term Debt Long-term obligations
$61.64B
↑ +7.4%

Health Breakdown

Profitability
70
Returns
64
Financial Health
39
Cash Quality
72

Dividend History

Dividend / share · sourced from SEC filings
$1.72 Latest / share
+1.8% YoY
+4.7% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters